BIOMAT Database Logo BIOMAT Database Logo

Innate immune response: ally or enemy in cutaneous leishmaniasis? 2021

Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Grupo de Investigación en Ciencias de la Educación y de la Salud (ICES), UNISANGIL, San Gil, Colombia.

Cutaneous leishmaniasis (CL) is an infectious and neglected disease caused by parasites of the genus Leishmania, which produces a wide spectrum of cutaneous manifestations. CL research has shown that the innate immune activity of cells such as neutrophils, natural killers, macrophages, dendritic cells and the complement system are capable of controlling this infection. However, Leishmania can also modulate the immune activity of these cells to promote its own survival and proliferation at the intracellular level. This review discusses the role of the innate immune response in the control and spread of this infection.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007891 Leishmania A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi. Leishmania (Leishmania),Leishmania (Viannia),Leishmania leishmania,Leishmania viannia,Leishmania leishmanias,Leishmania viannias,Leishmanias,Leishmanias (Leishmania),Leishmanias (Viannia),leishmanias, Leishmania,viannias, Leishmania
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D006790 Host-Parasite Interactions The relationship between an invertebrate and another organism (the host), one of which lives at the expense of the other. Traditionally excluded from definition of parasites are pathogenic BACTERIA; FUNGI; VIRUSES; and PLANTS; though they may live parasitically. Host-Parasite Relations,Parasite-Host Relations,Host-Parasite Relationship,Parasite-Host Interactions,Host Parasite Interactions,Host Parasite Relations,Host Parasite Relationship,Host-Parasite Interaction,Host-Parasite Relation,Host-Parasite Relationships,Interaction, Host-Parasite,Interaction, Parasite-Host,Interactions, Host-Parasite,Interactions, Parasite-Host,Parasite Host Interactions,Parasite Host Relations,Parasite-Host Interaction,Parasite-Host Relation,Relation, Host-Parasite,Relation, Parasite-Host,Relations, Host-Parasite,Relations, Parasite-Host,Relationship, Host-Parasite,Relationships, Host-Parasite
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016773 Leishmaniasis, Cutaneous An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes. Leishmaniasis, American,Leishmaniasis, New World,Leishmaniasis, Old World,Oriental Sore,American Leishmaniasis,Cutaneous Leishmaniases,Cutaneous Leishmaniasis,Leishmaniases, Cutaneous,New World Leishmaniasis,Old World Leishmaniasis,Sore, Oriental

Related Publications

Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Time: ally or enemy.
May 1987, Trends & techniques in the contemporary dental laboratory,
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Eryptosis: Ally or Enemy.
January 2017, Current medicinal chemistry,
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Enemy or ally? Fasting as an essential regulator of immune responses.
May 2021, Trends in immunology,
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Osteoprotegerin in cardiovascular disease: ally or enemy?
January 2014, Current pharmaceutical design,
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
[Pain in internal diseases: enemy or ally?].
October 1983, Polskie Archiwum Medycyny Wewnetrznej,
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Topography-mediated immunomodulation in osseointegration; Ally or Enemy.
December 2022, Biomaterials,
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Probiotics: an obedient ally or an insidious enemy?
November 2012, Critical care (London, England),
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Acidic pH: enemy or ally for enteric bacteria?
January 2012, Virulence,
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Cell-mediated immune response in cutaneous leishmaniasis.
December 1985, Journal of the Egyptian Society of Parasitology,
Héctor Serrano-Coll, and Nora Cardona-Castro, and Ana Pilar Ramos, and Alejandro Llanos-Cuentas
Exercise and Bone Health in Cancer: Enemy or Ally?
December 2022, Cancers,
Copied contents to your clipboard!